Showing 1 - 10 results of 10 for search 'Karina J. Yoon', query time: 0.04s Refine Results
  1. 1
    Patient-Derived Xenograft Models of Pancreatic Cancer: Overview and Comparison with Other Types of Models

    Patient-Derived Xenograft Models of Pancreatic Cancer: Overview and Comparison with Other Types of Models by Patrick L. Garcia, Aubrey L. Miller, Karina J. Yoon

    Published 2020-05-01
    Get full text
    Article
  2. 2
    Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma

    Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma by Laura L. Stafman, Adele P. Williams, Evan F. Garner, Jamie M. Aye, Jerry E. Stewart, Karina J. Yoon, Kimberly Whelan, Elizabeth A. Beierle

    Published 2019-02-01
    Get full text
    Article
  3. 3
    The BET Inhibitor JQ1 Potentiates the Anticlonogenic Effect of Radiation in Pancreatic Cancer Cells

    The BET Inhibitor JQ1 Potentiates the Anticlonogenic Effect of Radiation in Pancreatic Cancer Cells by Patrick L. Garcia, Aubrey L. Miller, Ling Zeng, Ling Zeng, Robert C. A. M. van Waardenburg, Eddy S. Yang, Eddy S. Yang, Eddy S. Yang, Karina J. Yoon

    Published 2022-06-01
    Get full text
    Article
  4. 4
    The BET inhibitor JQ1 attenuates double-strand break repair and sensitizes models of pancreatic ductal adenocarcinoma to PARP inhibitorsResearch in context

    The BET inhibitor JQ1 attenuates double-strand break repair and sensitizes models of pancreatic ductal adenocarcinoma to PARP inhibitorsResearch in context by Aubrey L. Miller, Samuel C. Fehling, Patrick L. Garcia, Tracy L. Gamblin, Leona N. Council, Robert C.A.M. van Waardenburg, Eddy S. Yang, James E. Bradner, Karina J. Yoon

    Published 2019-06-01
    Get full text
    Article
  5. 5
    The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer

    The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer by Aubrey L. Miller, Patrick L. Garcia, Samuel C. Fehling, Tracy L. Gamblin, Rebecca B. Vance, Leona N. Council, Dongquan Chen, Eddy S. Yang, Robert C. A. M. van Waardenburg, Karina J. Yoon

    Published 2021-07-01
    Get full text
    Article
  6. 6
    PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma

    PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma by Raoud Marayati, Laura L. Stafman, Adele P. Williams, Laura V. Bownes, Colin H. Quinn, Jamie M. Aye, Jerry E. Stewart, Karina J. Yoon, Joshua C. Anderson, Christopher D. Willey, Elizabeth A. Beierle

    Published 2021-03-01
    Get full text
    Article
  7. 7
    EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth.

    EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth. by Laura V Bownes, Adele P Williams, Raoud Marayati, Laura L Stafman, Hooper Markert, Colin H Quinn, Nikita Wadhwani, Jamie M Aye, Jerry E Stewart, Karina J Yoon, Elizabeth Mroczek-Musulman, Elizabeth A Beierle

    Published 2021-01-01
    Get full text
    Article
  8. 8
    Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma

    Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma by Laura V. Bownes, Raoud Marayati, Colin H. Quinn, Andee M. Beierle, Sara C. Hutchins, Janet R. Julson, Michael H. Erwin, Jerry E. Stewart, Elizabeth Mroczek-Musulman, Michael Ohlmeyer, Jamie M. Aye, Karina J. Yoon, Elizabeth A. Beierle

    Published 2022-04-01
    Get full text
    Article
  9. 9
    Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy

    Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy by Colin H. Quinn, Andee M. Beierle, Sara Claire Hutchins, Raoud Marayati, Laura V. Bownes, Jerry E. Stewart, Hooper R. Markert, Michael H. Erwin, Jamie M. Aye, Karina J. Yoon, Gregory K. Friedman, Christopher D. Willey, James M. Markert, Elizabeth A. Beierle

    Published 2022-02-01
    Get full text
    Article
  10. 10
    Pediatric Anaplastic Embryonal Rhabdomyosarcoma: Targeted Therapy Guided by Genetic Analysis and a Patient-Derived Xenograft Study

    Pediatric Anaplastic Embryonal Rhabdomyosarcoma: Targeted Therapy Guided by Genetic Analysis and a Patient-Derived Xenograft Study by Stuart L. Cramer, Aubrey L. Miller, Joseph G. Pressey, Tracy L. Gamblin, Elizabeth A. Beierle, Brian D. Kulbersh, Patrick L. Garcia, Leona N. Council, Leona N. Council, Rupa Radhakrishnan, Skyler V. Hendrix, Skyler V. Hendrix, David R. Kelly, David R. Kelly, Raymond G. Watts, Karina J. Yoon

    Published 2018-01-01
    Get full text
    Article

Search Tools: